906 followers
New article: Inhibition of miR-185-3p Confers Erlotinib Resistance Through Upregulation of PFKL/MET in Lung Cancers https://t.co/SRG79cMHVY #lungcancer #oncology https://t.co/6P0lXC3JgO
New article: Inhibition of miR-185-3p Confers Erlotinib Resistance Through Upregulation of PFKL/MET in Lung Cancers https://t.co/SRG79cMHVY #lungcancer #oncology https://t.co/6P0lXC3JgO
New Research: Inhibition of miR-185-3p Confers Erlotinib Resistance Through Upregulation of PFKL/MET in Lung Cancers: Erlotinib (ER), as an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), has a significant therapeutic… https://t.co